drugset / Trial / NCT03464461

Dosing of Ketorolac in the Emergency Department

NCT03464461

Phase 4 Terminated 289 enrolled University of Missouri-Columbia
RandomizedParallel-groupDouble-blindTreatment

Summary

The optimal dose of ketorolac in the Emergency Department setting is no clear. We will compare 3 doses to determine the optimal dose.

Timeline

Start
2018-05-01
Primary completion
2024-05-30
Completion
2024-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 10 mg Intravenous
Comparator Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.